The projects were awarded to Chindex’s German subsidiary, Chindex China-Export. Shipments under these contracts are expected to begin before the end of 2008 after certain administrative matters are
Copaxone is indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis. Craig Wheeler, president and CEO of Momenta, said: “Advancing the M356
According to the company, this acquisition was completed to help bring exciting options to the alternative and natural health sector by MindfulEye. MNI Nutraceuticals is a company focused
The joint venture expects to generate immediate revenue from rifampin launch and from several other new product launches in the second half of 2008. Rifampin is used in
Brendan’s StatLIA software allows researchers to quantitate proteins with measurable accuracy and improve assay performance through automated quality control. StatLIA also helps researchers troubleshoot sample preparation problems using
Since 2006, Ms Hoffing has served as president and CEO of Applied NeuroSolutions. Ms Hoffing has also served as chairman of Applied NeuroSolutions’s board of directors since December
The group of eight countries has contributed to progress in the war against HIV/AIDS and other major diseases like Polio, which it said, are closer to eradication than
According to the company, the HydroSteer line of guidewires features a lubricious hydrophilic coating which becomes slippery when wet, thereby reducing friction and enabling physicians to more easily
Using the proprietary controlled chaos technology (CCT), this next generation fractional CO2 laser is said to be designed to offer a safe and innovative way to treat deep
BioAlliance Pharma’s Loramyc is now available in four European countries and will be commercialized in the UK, Germany and Denmark by SpeBio. With the UK, Germany and Denmark,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.